The company said, “Over the past several quarters, the Company has strengthened its Board of Directors, terminated common stock sales under its ATM program, implemented a reduction-in-force, and phased-out its legacy ADVANCE(R) business. As a result, operating expenses and cash usage have been lowered by over $0.5M per quarter. The Company continues to build the Quell Fibromyalgia business via direct-to-physician marketing and sales to Veterans Health Administration facilities. “
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.